A hitchhiker's guide to antisense and nonantisense biochemical pathways

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
A D Branch

Abstract

Antisense pharmaceutical research has sought to provide drugs that would yield effective therapies for diseases resulting from the production of deleterious proteins. The original concept was straightforward: eliminate production of unwanted proteins, such as oncogenic proteins, by blocking the function of their mRNAs; and block their mRNAs by adding "antisense" nucleic acids that bind them through complementary base pairing. However, it has proven difficult to develop clinically useful antisense strategies. Conventional antisense nucleic acids are large, highly charged, complex molecules that interact with a wide variety of unintended cellular and microbial components, often causing "nonantisense effects." It is now clear that a broad knowledge of nucleic acid biochemistry will be needed to optimize antisense molecules for use in patients. The efficacy of naturally occurring antisense molecules and the success of antisense agricultural strategies prove that antisense approaches can be powerful and specific. Pharmaceutical antisense research can be expected to yield many valuable products once sufficient information about antisense mechanisms has been gathered and applied. This article explains the biochemical events that give ...Continue Reading

Citations

Oct 26, 1999·Drug Discovery Today·M A Walker
Mar 1, 2012·Bioconjugate Chemistry·Mouna RaouanePatrick Couvreur
Mar 22, 2003·American Journal of Respiratory Cell and Molecular Biology·Cherie D FosterSusan H Guttentag
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·B W JohnsonS Higgs
Jan 26, 2008·Advances in Medical Sciences·H E Blum
Jul 5, 2005·Expert Opinion on Investigational Drugs·C F Bennett
Dec 1, 2001·Expert Opinion on Biological Therapy·A SandrasagraJ W Nyce
Jan 5, 2002·Expert Opinion on Investigational Drugs·N N Zein
Jul 5, 2005·Expert Opinion on Investigational Drugs·J WuM A Zern
Aug 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F von WeizsäckerH E Blum
Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordan FeldStephen Locarnini
Dec 4, 2003·Nature Biotechnology·Lisa J Scherer, John J Rossi
May 17, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Howard A BallJonathan W Nyce
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul D Berk
Mar 22, 2001·Journal of Internal Medicine·A M Larson, R L Carithers
Jan 22, 2003·Journal of Gastroenterology and Hepatology·Robert Y M ChenStephen A Locarnini
Feb 7, 1998·Journal of Pharmaceutical Sciences·R M BrandP L Iversen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.